Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A glutamatergic model of ECT-induced memory dysfunction

E Chamberlin1, G E Tsai

  • 1Institute of Living, Hartford, Conn., USA.

Harvard Review of Psychiatry
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultimate Translation: Developing Therapeutics Targeting on N-Methyl-d-Aspartate Receptor.

Advances in pharmacology (San Diego, Calif.)·2016
Same author

[Blood supply topographic features in maxilla and mandible].

Stomatologiia·2015
Same author

Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals.

Molecular psychiatry·2013
Same author

[Blood supply in maxilla after segmental osteotomy].

Stomatologiia·2013
Same author

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.

Molecular psychiatry·2008
Same author

[Computer modelling and topographo-anatomic substantiation of TMJ ankylosis surgical treatment].

Stomatologiia·2008

Electroconvulsive therapy (ECT) effectively treats several neuropsychiatric conditions. However, a proposed glutamatergic model suggests ECT-induced memory dysfunction stems from excessive glutamate release, offering targets for prevention.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Electroconvulsive therapy (ECT) is a proven treatment for major depression, mania, and other neuropsychiatric disorders.
  • ECT-induced memory dysfunction is a significant clinical concern, impacting patient and provider decisions.
  • Understanding the mechanisms of memory impairment is crucial for improving ECT safety and efficacy.

Purpose of the Study:

  • To review existing literature on ECT-induced memory dysfunction.
  • To propose a novel glutamatergic model for ECT-induced memory dysfunction.
  • To identify potential therapeutic targets for mitigating memory side effects.

Main Methods:

  • A Medline search was conducted using terms "electroconvulsion" and "glutamate" in English.

Related Experiment Videos

  • Literature review focused on the neurobiological underpinnings of ECT.
  • A theoretical model was developed based on current understanding of glutamatergic neurotransmission.

    • Main Results:

    • Excessive release of excitatory amino acids, particularly glutamate, is implicated in ECT's effects.
    • Activation of glutamate receptors may lead to neuronal insults via cation and water flux.
    • Reversible oxidative stress is proposed as a contributing factor to memory dysfunction.

    Conclusions:

    • The glutamatergic model provides a framework for understanding ECT-induced memory dysfunction.
    • This model generates testable hypotheses regarding risk factors and therapeutic interventions.
    • Further research into this model may lead to strategies for preventing and treating memory-related side effects of ECT.